Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 298 participants.
Also called NCT06704633
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 298 participants
- Sponsor
- Martin Rohacek
- Registry
-
NCT06704633
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Tanzania
- Registry status
- Recruiting
Technical summary
Registry record NCT06704633. Allocation not applicable; no masking; primary purpose treatment. Start 2026-06-30 (actual); primary completion 2028-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania
- Condition
- Heart Failure
- Intervention (Drug)
- Sacubitril / Valsartan Oral Tablet
- Lead sponsor
- Martin Rohacek
- Collaborator
- Ifakara Health Institute
Record details
- Record id
cardio:ct-nct06704633- Content hash
9b5c4c4c05e8beb4f184e9700e11b19379ac52f897f81ca565a7d10f0f3a2ddc